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Abstract  
Aims: The Pathogenesis of penile squamous cell carcinoma (PSCC) is not well understood. 
Human papillomavirus (HPV) may be involved in carcinogenesis, but few studies have 
compared the cell-cycle protein expression in HPV positive and negative cancers of this 
type. The aim was to determine the extent of HPV infection in different histological subtypes 
of PSCC and its impact on the expression of key cell cycle proteins: p53, p21, p16INK4A and 
RB. 
Methods and Results: We examined 148 PSCC samples immunohistochemically for RB, 
p16INK4A, p53 and p21 protein expression. 102 cases were typed for HPV by PCR. HPV DNA 
was detected in 56% of tumours with HPV16 present in 81%.  Marked differences were 
observed in HPV prevalence and RB and p16INK4A expression between tumour subtypes. RB 
protein negatively (p<0.0001) and p16INK4A (p<0.0001) and p21 (p=0.0002) positively 
correlated with HPV infection. Conclusions: HPV infection is present in over half of penile 
cancers and it is responsible for RB pathway disruption in those tumours. However, no link 
between HPV and p53 immunodetection was found.  Different histological subtypes of PSSC 
express HPV DNA at different levels, confirming possible separate aetiologies for those 
tumours.  
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Introduction 
Penile carcinoma is rare in developed countries, representing 0.3-0.5% of male 
malignancies in Europe and the USA 1. In the UK there are approximately 600 (rate 1 per 
100 000) new cases each year, mostly after the sixth decade 1, 2. The vast majority (95%) 
are squamous cell carcinomas 3. These may be divided into usual type (70%), followed by 
more aggressive basaloid (10%) and a slow growing, low grade group of ‘verruciform’ 
tumours (20%). Verruciform lesions include verrucous carcinoma, warty carcinoma and 
papillary squamous cell carcinomas 4. Mixed tumours of usual type and one or more of other 
subtypes of SCC also exist.  
Risk factors for penile cancer include lack of circumcision during childhood, phimosis and 
cigarette smoking 5. There is some confusion on the role of infection with human 
papillomavirus  in penile cancer 3, as contrary to cervical cancer 6 the incidence rate varies 
significantly from 15% to 77.5% 7, 8, depending on detection range, population studied and 
tumour type 9. HPV16 is most prevalent infection 7, similar to other HPV-related ano-genital 
cancers 10. Basaloid and warty tumours have been shown to be strongly associated with 
HPV infection 11. Therefore, penile cancer may resemble vulvar cancer, which has two 
different aetiologies, one related to HPV infection and one that is not 12.  
The carcinogenic abilities of high-risk HPV types are well known due to extensive studies on 
cervical cancer. Viral oncoproteins E6 and E7 can disrupt cell cycle checkpoints and 
apoptosis by respectively interacting with tumour suppressor proteins, RB and p53. RB 
regulates cell cycle progression, protecting the cell from uncontrolled proliferation and is 
regulated by cyclin dependent kinase phosphorylation. p16INK4A can inhibit cyclin dependent 
kinase mediated RB phosphorylation, preventing cell cycle progression. In cells infected with 
high-risk HPV, viral E7 protein binds directly to RB causing its inactivation and 
downregulation, which prevents cell-cycle control by p16INK4A  13, 14. In these circumstances 
accumulation of p16INK4A can occur, which is an indication of HPV infection 15. p53 can also 
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inhibit cancer development and tumour growth through its ability to efficiently inhibit cell 
proliferation and promote apoptotic cell death 16. In cancers harbouring high-risk HPV, 
expression of viral E6 protein can inactivate p53 through its downregulation and an inverse 
correlation between HPV positivity and p53 overexpression has been found in some cancer 
sites but not others 17. HPV E7 protein can additionally overcome the inhibitory function of 
p21. p21 is a p53-responsive protein and arrests cell cycle in presence of DNA damage. E7 
protein binds to p21 and abrogates its inhibitory functions, therefore overcoming a DNA 
damage-induced cell cycle arrest despite high levels of p21 18. 
The mechanisms of oncogenesis in penile cancer are not fully understood. There are no 
data on RB expression in penile cancer and results on p53 in relation to HPV are 
inconclusive. Limited data is available on p16INK4A immunodetection 19, 20 and p21 expression 
21 in penile tumours. Therefore, we investigated HPV infection type in one of the largest 
series of penile SCC to test the hypothesis that HPV type and its association with key cell 
cycle proteins had differential effects on the tumour subtypes, in order to elucidate their role 
in tumour pathogenesis. 
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Materials and Methods 
The study was conducted upon approval from East London and The City Research Ethics 
Committee. We retrospectively reviewed the Cellular Pathology Department Registry of St 
George’s Hospital to identify patients treated for penile SCC between 2001 - 2007. We 
retrieved 148 penile SCCs. 97 samples were usual type SCCs, 17 basaloid, 15 pure 
verrucous carcinomas, 7 mixed verrucous/usual type, 7 mixed verrucous/warty, 2 warty and 
3 warty/usual types. 21 cases were obtained from excision biopsies/circumcisions, 82 from 
glansectomies and 45 from partial/total penectomies. All cases were re-reviewed by an 
expert uropathologist (C.C.) including subtyping, grading and staging by standard 
methodologies 4, 22.  
Polymerase chain reaction (PCR).  
102 wax blocks from penile SCC cases were suitable for DNA extraction with a QIAamp 
DNA Mini kit (51304; Qiagen, Crawley, U.K.). Beta-Globin polymerase chain reaction was 
performed using primers B1 and B19 to confirm the adequacy of the extracted DNA. 
Validated samples were tested for the presence of HPV DNA by a broad-spectrum HPV 
PCR method using SPF10 primers which amplify a 65-bp fragment of the L1 open reading 
frame and HPV genotypes identified by the INNO-LiPA line probe assay (Innogenetics NV, 
Ghent, Belgium) 19.  
Immunohistochemistry. 
Tissue microarray blocks were prepared using a manual microarrayer. Three x 1mm tissue 
cores were taken from each tumour. Four um sections were cut and immunostained using 
standard heat-induced antigen retrieval methods and the ABC kit (Vector Laboratories, PK-
6200), according to manufacturer instructions 23. Primary antibodies dilutions were: 1:50 for 
RB (Novocastra, NCL-RB-358), 1:100 for p16INK4A (Neomarkers, MS-1064-PO), 1:1000 for 
p53 (Dako, M7001) and p21 (Dako, M7202). Positive controls included CIN III for p16INK4A, 
placenta for p21, anaplastic thyroid cancer for p53 and tonsil for RB. The staining pattern of 
RB, p53 and p21 was nuclear. p16INK4A showed both nuclear and cytoplasmic staining.  
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Sections were scored semiquantitatively by a consultant genitourinary pathologist (D.B.). For 
nuclear positivity each core was given an estimated visual score between 0 – 100%, 
representing the percentage of positively stained neoplastic nuclei. The intensity of staining 
was also measured as: 1 (weak), 2 (medium) and 3 (strong). The final score was deduced 
by multiplying the percentage of staining by intensity to give an expression score from 0-300. 
p53 expression was always strong; therefore nuclear score alone was applied. Cytoplasmic 
expression of p16INK4A was determined by intensity of staining alone. The core with highest 
score was selected for analysis. Statistical analysis was performed using StatsDirect 
software, version 2.60.6000. The correlations between antibodies were evaluated using 
Spearman’s rank correlation test and the tumour type or HPV infection was evaluated by 
Chi-Square test or Fisher’s exact probability test. Comparisons between antibodies 
expression in different histological subtypes of SCCs were restricted to usual type, verrucous 
and basaloid only. The warty group of tumours was too heterogeneous and included only 2 
pure warty samples. The cut-off points selected for antibody positivity were: >0 for p16INK4A, 
≥5 for p53, ≥10 for p21 and ≥240 for RB. All analyses were 2-sided, p<0.05 was considered 
to be significant.  
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Results  
148 tumours were analysed which comprised 97 usual type SCCs, 17 basaloid, 15 
verrucous, 7 mixed verrucous/usual type and 12 mixed warty and other SCC subtypes. The 
histopathological features of the tumours are listed in Table 1. Of these, 102 cases were also 
suitable for HPV analysis. 
HPV infection 
HPV DNA was detected in 57/102 (56%) penile SCCs. Of these HPV positive tumours, 
39/57 (68%) were single and 18/57 (32%) multiple HPV type infections containing up to 6 
low and high risk HPV types (Table 2). High-risk type 16 was the most prevalent type, 
present in 46/57 (81%) of HPV positive tumours. HPV18 was not detected. In the majority of 
HPV positive tumours, 33/57 (58%) HPV16 was the only HPV type detected (Table 2). 
Differences in the HPV infections were observed between the histological subtypes of 
PSCC. For the usual type, HPV DNA was detected in 38/64 (59%) tumours, with high risk 
HPV16 present in 33/38 (87%) cases. Mixed warty subtypes were positive for HPV DNA in 
6/11 (55%) cases, with HPV16 present in 3/6 (50%) cases. Basaloid tumours showed higher 
positivity, 10/13 (77%) for HPV DNA, with HPV type 16 present in 100% of these cases. In 
contrast, HPV was detected in only 3/13 (23%) verrucous tumours and HPV16 was not 
found (0%).  
Immunohistochemistry 
The positive expression of proteins and mean values are listed in Table 3. High RB 
expression (Figure 1A) was detected in 85/147 (58%) of penile SCC and significant 
differences were observed between histological groups (p<0.0001).  A high percentage of 
verrucous cases (87%), an intermediate number of usual type (60%) and few basaloid 
cancers (12%) expressed high RB levels. The mean RB expression was two-fold lower in 
basaloid than in verrucous and usual subtypes.  
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p16INK4A demonstrated both nuclear and cytoplasmic staining (Figure 1B). Overall 47% of 
PSCCs are positive for cytoplasmic p16INK4A expression, with significant differences between 
histological groups: 13% of verrucous, 48% usual and 94% of basaloid cases were p16INK4A 
positive. Basaloid samples had very high mean expression of nuclear and cytoplasmic 
p16INK4A, while mean expression of p16INK4A in verrucous samples was very low and usual 
type showed intermediate values. There was a significant inverse correlation between RB 
and p16INK4A expression (p<0.0001) in penile SCCs.  
 
p53 immunodetection (Figure 1C) showed no significant difference between histological 
subtypes of SCC and was present in 79% of cases overall. Intensity of p21 staining was 
weak (Figure 1D) and present in 62%, with no difference in the expression between different 
SCC subtypes. No relationship was detected between p53 and p21 expression. There was a 
positive correlation between p21 and p16INK4A expression (Spearman’s ρ = 0.658793, 
p<0.0001) and negative correlation with RB (Spearman’s ρ = -0.499952, p<0.0001).  
 
There was also a strong positive correlation between HPV infection and p21 (p=0.0002) and 
p16INK4A (p<0.0001) immunodetection and negative correlation with RB expression 
(p<0.0001) in penile SCC. p53 did not show any correlation with HPV infection (p=0.5682). 
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Discussion  
The rate of HPV infection in penile cancer varies widely, depending on the population 
studied and sensitivity and specificity of the method used.  Our results suggest that in a 
developed country, unlike cervical cancer, penile cancer has at least two aetiologies: one 
HPV related and one unrelated (similar to vulvar cancer) as we detected HPV DNA in 56% 
(57/102) of PSCC cases. This is consistent with our previous report of HPV prevalence in 
PSCC of 54% 19 and the recent review that found 48% of 1,266 cases from 30 studies of 
invasive penile cancer were HPV positive 24. We confirm existence of differences in HPV 
infection between histological subtypes 11. HPV prevalence in usual type SCC varies 
between 11% and 71% 7, 8, 25, and 59% (38/64) reported by us falls well within this range. As 
previously reported by our group , verrucous tumours were mostly HPV negative confirming 
the lack of HPV involvement in this neoplasm 26, while basaloid carcinomas showed strong 
correlation to HPV infection 11, 25.  
HPV16 is the most prevalent type in our study and was detected in 81% (46/57) of positive 
samples and in over half of these as a single infection suggesting that this HPV genotype is 
more likely to contribute to the carcinogenic process.  
Comparing these results with protein expression reveals that basaloid tumours have an 
aetiology related to high-risk HPV infection, which manifests itself in high p16INK4A and 
decreased RB expression, as has been shown in cervical cancer 27. The aetiology of usual 
type SCC can only be attributed to HPV infection in approximately half of the tumours, 
showing corresponding loss of RB and gain of p16INK4A protein expression. This is analogous 
to the involvement reported for HPV in carcinogenesis of anal SCC 28 and tonsillar 
carcinoma 29. 
Detection of p53 protein by immunohistochemistry in penile cancer varies between 41.5% 
and 89% 21, 30, 31 and there is a lack of reports comparing different histological types. We 
detected p53 immunostaining in 79% (103/143) of penile SCCs and the value was very 
similar regardless of histology (Table 3). There was no correlation between high-risk HPV 
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infection and p53 immunostaining, which is in agreement with previous reports on penile 
SCC 30, 31.  
p21 was expressed in 62% (88/143) of penile SCC with no significant difference between 
tumour subtypes. Lam and Chan 21 showed lower p21 expression in penile cancer but on 
much smaller cohort. Interestingly p21 did not correlate with p53 and some cases expressed 
high levels of p21 despite low or absent p53 protein, suggesting p53-independent activation 
of p21. Surprisingly, similar to tonsilar SCC 29, we found positive correlation of p21 with HPV 
infection (p=0.0002). Additionally, p21 positively correlated with p16INK4A (p<0.0001) and 
negatively with RB expression (p<0.0001). Funk at al 18 reported that high-risk HPV16 E7 
protein can directly bind to p21 and abrogate a DNA damage-induced cell cycle arrest, 
despite high levels of p21. He suggested it is possible that the release of E2F from RB and 
inactivation of p16INK4A and p21 are all necessary for the ability of E7 to bypass cell cycle 
arrest signals. On the other hand, there is emerging evidence that p21 in certain cancers 
may itself act as an oncogene and actually promote proliferation 32. 
To our knowledge this is the largest study to examine penile cancer pathogenesis by 
comparing HPV type with proteins commonly affected by HPV infection. We demonstrated, 
for the first time, that HPV infection in penile SCC disrupts the RB/ p16INK4A pathway through 
downregulation of RB and elimination of cell-cycle control from p16INK4A , manifesting itself in 
accumulation of p16INK4A , which fails to block cell cycle progression. p21 was widely 
expressed, consistent with abnormal cell cycle regulation. However, p21 seems to be 
regulated independently from p53 and may be involved in oncogenic process. We confirm 
that penile tumours seem to have two different aetiologies: one related to HPV and one 
unrelated. These data suggest that use of the bivalent HPV16/18 prophylactic vaccine in 
men could reduce occurrence of penile SCC by about 45%.  
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Table 1. Histological grade and stage of different subtypes of penile squamous cell carcinoma 
     
 
     SCC subtype 
  
Grade  (1-3)  
 
Stage (1-4) 
  
     
 
     
  
1 2 3  1 2 3 4 No data 
All SCCs n=148 36 59 54  48 70 16 7 6 
Usual type n=97 13 49 35  28 46 12 6 5 
Verrucous n=15 12 3 0  8 7 0 0 0 
Basaloid n=17 0 2 15  5 7 3 1 1 
Mixed warty n=12 9 2 1  7 4 1 0 0 
     
 
     
 SCC, squamous cell carcinoma; No data, there was no tumour stage available for six patients, which underwent 
penile circumcision or excision biopsy. 
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Table 2. Human papillomavirus DNA detection by polymerase chain reaction method in different histological subtypes of penile squamous cell 
carcinoma  
  
  HPV genotype distribution 
                      Histological subtype of SCC n HPV 6 11 16 33 6 11 11 16 16 16 16 31 51 6 11 6 31 6 X 
  
DNA 
    
16 16 45 31 35 45 52 33 52 11 16 16 33 11 
 
  
positive 
             
16 31 33 44 16 
 
                  
45 45 31 
 
                    
33 
 
                    
45 
 Usual type  64 38 (59%) 2 1 24 0 1 3 1 1 0 2 0 0 0 1 0 1 0 0 1 
Basaloid  13 10 (77%) 0 0 9 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
Verrucous  13 3 (23%) 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 
Mixed verrucous/usual type  1 0 (0%) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Mixed warty  11 6 (55%)  0 1 0 1 0 0 0 0 1 0 0 1 0 0 1 0 0 1 0 
                                            
                      SCC, squamous cell carcinoma; HPV, human papillomavirus; X, unclassified HPV genotype. 
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Table 3. Positive expression of RB, nuclear and cytoplasmic p16INK4A, p53, p21 and Ki67 in all penile squamous cell carcinomas and in regard  
to histological subtypes  
 
 
 
 
           SCC 
subtype RB (≥240) nuc p16INK4A  (>0) cyt p16INK4A  (>0) p53 (≥ 5%) p21 (≥ 10% ) 
      
      
 
n (%) mean n (%) mean  n (%) mean  n (%) mean  n (%) mean  
           
           All SCCs 85/147 (58) 205.6  65/144 (45) 54.2 67/144 (47) 1.1  113/143 (79) 19.4 88/143 (62) 38.1 
Usual type 58/97 (60) 212  48/93 (48) 62.3 48/93 (48) 1.2 75/93 (81) 20.9 58/94 (62) 41.7  
Verrucous 13/15 (87) 248  1/15 (7) 2.7  2/15 (13) 0.1  13/15 (87) 15.4  8/13 (62) 17.8  
Basaloid 2/17 (12) 118.2  16/17 (94) 102.4 16/17 (94) 2.2  14/17 (82) 17.5  15/17 (88) 47.4  
Mixed warty 6/11 (55) 199  2/12 (17) 16.7 3/12 (25) 0.4  7/12 (58) 7.8  5/12 (42) 30.4  
           
           nuc p16INK4A , nuclear p16INK4A ; cyt p16INK4A , cytoplasmic p16INK4A  
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Titles and legends to Figures 
Figure 1. Immunostaining results for penile squamous cell carcinoma. (A) Strong RB 
expression throughout the tumour. (B) p16INK4A expression showing both cytoplasmic and 
nuclear positivity. (C) Strong positivity of p53 in basal areas of the tumour. (D) p21 
expression, showing scattered staining only 
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carcinoma 
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Table 3. Positive expression of RB, nuclear and cytoplasmic p16INK4A, p53, p21 and Ki67 in 
all penile squamous cell carcinomas and in regard to histological subtypes 
 
 
 
 
 
 
 
 
 
